论文部分内容阅读
就发生率、流行率、发病率、死亡率及医疗费用而言,心力衰竭(HF)仍然是公共重要的医疗健康问题, 尽管采用了最佳药物治疗,死亡率仍极高,因慢性心力衰竭(CHF)恶化住院患者4年死亡率高达60％。最初HF的治疗目的主要是改善症状,近10年治疗模式已转变为改善疾病的过程和延长患者生命。利尿剂、血管紧张素转换酶抑制剂(ACEI)、β阻滞剂、地高辛
Heart failure (HF) remains a public health problem of importance in terms of prevalence, prevalence, morbidity, mortality and medical costs. Despite the best medical treatment, mortality is still extremely high due to chronic heart failure (CHF) worsening 4-year mortality in hospitalized patients up to 60%. The initial HF treatment is mainly to improve the symptoms, the treatment model has been transformed into the past 10 years to improve the disease process and prolong the life of patients. Diuretics, angiotensin-converting enzyme inhibitors (ACEIs), beta blockers, digoxin